Dysport 500 IU

Dysport® 500 IU is a prescription injectable medication containing 500 International Units (IU) of abobotulinumtoxinA, a purified botulinum toxin type A. It is widely used in aesthetic medicine and various medical specialties to temporarily reduce excessive muscle activity, helping improve the appearance of dynamic facial wrinkles and treat certain neuromuscular disorders. Dysport should only be administered by qualified healthcare professionals experienced in botulinum toxin injection techniques. The active ingredient is: Dysport Dysport 500 IU is supplied as a sterile, lyophilized (freeze-dried) powder in a single-use vial. Before administration, it is reconstituted with preservative-free sterile saline according to the manufacturer’s instructions. The dosage and injection sites are determined by the healthcare provider based on the patient’s condition, treatment goals, and the approved indication. The potency units of Dysport are specific to this product and are not interchangeable with those of other botulinum toxin products.

Composition

Each 500 IU vial typically contains:

• 500 International Units (IU) of abobotulinumtoxinA
• Human serum albumin
• Lactose monohydrate

The formulation is preservative-free and intended for single-patient use after reconstitution.

Storage Requirements

To maintain product quality:

• Store refrigerated according to the manufacturer’s labeling.
• Protect from excessive heat and direct sunlight.
• Reconstitute only with preservative-free sterile saline.
• Use the reconstituted solution within the manufacturer’s recommended timeframe.
• Follow aseptic handling procedures during preparation and administration.

Safety Information

Dysport is a prescription medication and should only be administered by qualified healthcare professionals.

It may not be appropriate for individuals with:

• Known hypersensitivity to any component of the formulation
• Infection at the intended injection site
• Certain neuromuscular disorders

Possible side effects include:

• Injection-site pain or bruising
• Headache
• Temporary eyelid drooping
• Localized muscle weakness
• Swelling or redness at the injection site

Serious adverse reactions, including difficulty swallowing, speaking, or breathing, are uncommon but require immediate medical attention.

Mechanism of Action

Dysport works by temporarily blocking the release of acetylcholine at the neuromuscular junction, preventing nerve signals from stimulating targeted muscles.

This results in:

• Temporary muscle relaxation
• Reduction of dynamic facial wrinkles
• Relief of involuntary muscle contractions
• Improvement in muscle overactivity associated with approved medical conditions

Product Features

• 500 IU potency per vial
• Purified abobotulinumtoxinA formulation
• Sterile lyophilized powder
• Precise dosing by trained healthcare professionals
• Suitable for approved aesthetic and therapeutic applications
• Single-use vial

1. Minimally Invasive

Provides treatment without the need for surgery.

2. Fast Onset

Many patients begin to notice visible improvements within a few days.

3. Clinically Established

Widely used for approved medical and cosmetic indications.

4. Temporary and Adjustable

Effects gradually diminish, allowing individualized retreatment schedules.

5. Broad Clinical Applications

Used across dermatology, neurology, ophthalmology, and rehabilitation medicine.

Cosmetic Uses

Depending on local regulatory approvals, Dysport may be used to temporarily improve the appearance of:

• Glabellar (frown) lines
• Forehead lines
• Crow’s feet
• Other dynamic facial wrinkles as determined by a qualified healthcare professional

Medical Uses

Depending on country-specific regulatory approvals, Dysport may be prescribed for:

• Cervical dystonia
• Upper and lower limb spasticity
• Blepharospasm
• Hemifacial spasm
• Pediatric spasticity associated with cerebral palsy
• Other approved neuromuscular disorders

Approved indications vary by country and regulatory authority.

Typical Duration of Effect

Treatment response varies depending on the indication, dosage, injection technique, and individual patient factors.

Typical cosmetic outcomes include:

• Initial improvement within 2–3 days
• Maximum effect in approximately 1–2 weeks
• Duration of approximately 3–5 months, depending on the treatment area and patient response